Research Publications

Utility of on-line three-dimensional transesophageal echocardiography during percutaneous atrial septal defect closure.

Price MJ, Smith MR, Rubenson DS

Three-year outcome of drug-eluting stent implantation for coronary artery bifurcation lesions.

Stinis CT, Hu SP, Price MJ, Teirstein PS

Intraprocedural stent thrombosis during crush stenting of the left main coronary artery bifurcation.

Nayak KR, Mehta HS, Barker CM, Price MJ

Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.

Kandzari DE, Angiolillo DJ, Price MJ, Teirstein PS

Bedside evaluation of thienopyridine antiplatelet therapy.

Price MJ

Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.

Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

Price MJ, Berger PB, Angiolillo DJ, Teirstein PS, Tanguay JF, Kandzari DE, Cannon CP, Topol EJ

Monitoring platelet function to reduce the risk of ischemic and bleeding complications.

Price MJ

Safety and performance of targeted renal therapy: the Be-RITe! Registry.

Weisz G, Filby SJ, Cohen MG, Allie DE, Weinstock BS, Kyriazis D, Walker CM, Moses JW, Danna P, Fearon WF, Sachdev N, Wiechmann BN, Vora K, Findeiss L, Price MJ, Mehran R, Leon MB, Teirstein PS

Change we can believe in: the hyper-evolution of percutaneous coronary intervention for unprotected left main disease with drug-eluting stents.

Price MJ, Kandzari DE, Teirstein PS